New Subcutaneous Form of Tepezza Shows Similar Effectiveness to IV Version for Thyroid Eye Disease
Amgen, a biotechnology company, has shared promising results from a large clinical trial (Phase 3) testing a new under-the-skin injection […]
Pharmaceutical News
Experts Disagree on Alzheimer’s Drugs as New Review Questions Their Benefits
Two major drug companies, Eli Lilly and Eisai, are defending their Alzheimer’s disease treatments after a new review suggested they
New Treatment Approved for Heart Failure in the UK: Kerendia (finerenone)
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new medication called Kerendia (finerenone) for adults with
Pharmaceutical News
Gilead Sciences Buys German Biotech Company for $3.15 Billion to Boost Cancer Treatment Research
Gilead Sciences, a well-known pharmaceutical company, has agreed to purchase Tubulis, a German biotechnology company, for $3.15 billion upfront. This
Kainova Therapeutics Begins European Patient Enrollment in Groundbreaking Cancer Immunotherapy Trial
Kainova Therapeutics has started enrolling patients in Europe for an important early-stage clinical trial called the DOMISOL study. This trial
Pharmaceutical News
USP Warns of Risks in U.S. Drug Supply Chain Due to Dependence on Single-Source Materials
The United States Pharmacopeia (USP), a nonprofit organization that sets quality standards for medicines, has issued a new report highlighting
Pharmaceutical News
Major Changes in Pharmaceutical Partnerships and Investments: What It Means for Patients
This week, several important updates in the pharmaceutical industry could affect how medicines and vaccines are developed, distributed, and supplied
Oxford BioTherapeutics Partners with Bristol Myers Squibb to Develop New Cancer Treatments
Oxford BioTherapeutics (OBT) has started a long-term partnership with Bristol Myers Squibb (BMS) to create and develop new cancer therapies
Pharmaceutical News
Can Artificial Intelligence Really Revolutionize How New Medicines Are Developed?
Artificial Intelligence (AI) is being talked about as the future of drug development, with promises of faster, smarter, and more
Pharmaceutical News
New Research Shows Hope for Adults with Severe Depression: Combination Treatment Nearly Doubles Recovery Rates
A recent study has found that combining an antidepressant with a small molecule drug called Caplyta (lumateperone) can significantly improve